Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Mitchell

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Plos One|July 18, 2014
Identification of a new target of miR-16, Vacuolar Protein Sorting 4aNeeta Adhikari, Weihua Guan, Brian Capaldo, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study populationTonia C Carter, Faith Pangilinan, James F Troendle, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?Kobika Sritharan, Alex Dunlop, Jonathan Mohajer, et al.
Nanomaterials (Basel, Switzerland)|November 8, 2024
Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing MiceQingyu Zhou, John C Harding, Ping Fan, et al.
Clinical and Translational Radiation Oncology|May 13, 2020
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linacAlex Dunlop, Adam Mitchell, Alison Tree, et al.
Currents in Pharmacy Teaching & Learning|March 10, 2020
Design and implementation of a molecular imaging elective for third-year pharmacy studentsChristopher Whitman, Sainath Kamath, Shelby Lawrence, et al.
Clinical and Translational Radiation Oncology|July 3, 2025
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapyBethany Williams, Jonathan Mohajer, Sophie E Alexander, et al.
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2025
Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate CancerMathijs G Dassen, Alison C Tree, Lisa Wiersema, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Plos One|July 18, 2014
Identification of a new target of miR-16, Vacuolar Protein Sorting 4aNeeta Adhikari, Weihua Guan, Brian Capaldo, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study populationTonia C Carter, Faith Pangilinan, James F Troendle, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?Kobika Sritharan, Alex Dunlop, Jonathan Mohajer, et al.
Nanomaterials (Basel, Switzerland)|November 8, 2024
Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing MiceQingyu Zhou, John C Harding, Ping Fan, et al.
Clinical and Translational Radiation Oncology|May 13, 2020
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linacAlex Dunlop, Adam Mitchell, Alison Tree, et al.
Currents in Pharmacy Teaching & Learning|March 10, 2020
Design and implementation of a molecular imaging elective for third-year pharmacy studentsChristopher Whitman, Sainath Kamath, Shelby Lawrence, et al.
Clinical and Translational Radiation Oncology|July 3, 2025
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapyBethany Williams, Jonathan Mohajer, Sophie E Alexander, et al.
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2025
Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate CancerMathijs G Dassen, Alison C Tree, Lisa Wiersema, et al.
Pageof 7